Malad East, Mumbai, Maharashtra
Send E-mail
Send SMS
Home»Products»

Trastuzumab 440 mg

Trastuzumab Medicine usually is administered intravenously with an initial dose of 4 mg per kilogram of body weight followed by a weekly dose of 2 mg per kilogram of body weight. This is effectual in the treatment of an early stage breast cancer commonly found in the women.


REQUEST CALLBACK
Get Best Quote

Approx. Rs 500  / Piece Get Latest Price

Trastuzumab Drug is approved for the treatment of early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes, or is HER2+ and has not spread into the lymph nodes. If it has not spread into the lymph nodes, the cancer needs to be estrogen receptor/progesterone receptor (ER/PR)-negative or have one high risk feature.

Trastuzumab is approved to be used alone or with other drugs to treat:

 

  • Adenocarcinoma of the stomach or gastroesophageal junction. It is used for HER2 positive (HER2+) disease that has metastasized (spread to other parts of the body) in patients who have not already been treated for metastatic cancer

  • Breast cancer that is HER2+. It is used in patients whose disease has not gotten better with other chemotherapy

  • Trastuzumab usually is administered intravenously with an initial dose of 4 mg per kilogram of body weight followed by a weekly dose of 2 mg per kilogram of body weight

Yes! I am Interested
X
 

Download Brochure
Explore more products
Crizalk (Xalkori)
Get Best Quote
Yondelis 1 Mg Injection
Get Best Quote
Velcade 3.5 Mg
Get Best Quote
Oxaliplatin Injection
Get Best Quote
Gemcitabine HCL
Get Best Quote
3s Corporation

Piyansh Mantry(CEO)
B/22 Padamnagar CHS, Andheri Kurla Road, Andheri East
Malad East, Mumbai - 400101
Maharashtra, India
Send Email
© 3s Corporation. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited